Clinical Trials Logo

Tinea clinical trials

View clinical trials related to Tinea.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04315051 Terminated - Clinical trials for Interdigital Tinea Pedis

A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis

Start date: September 12, 2019
Phase: Phase 2
Study type: Interventional

Placebo Controlled Trial of the Safety and Efficacy of DBI-001 in Patients with Interdigital Tinea pedis (T. pedis)

NCT ID: NCT02842021 Terminated - Tinea Pedis Clinical Trials

Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis

Start date: September 2016
Phase: Phase 2
Study type: Interventional

To assess the efficacy and safety of a combination product S2G6T-1 compared to its monads and vehicle, applied twice daily for 7 days, in the treatment of symptomatic inflammatory interdigital tinea pedis in subjects 12 years of age and older. The results of this study will be utilized to perform power calculations for the Phase 3 pivotal trials.

NCT ID: NCT01119742 Terminated - Clinical trials for Interdigital Tinea Pedis

Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea Pedis

BNF-0909
Start date: July 2010
Phase: Phase 1
Study type: Interventional

To demonstrate comparable safety and efficacy of Taro Pharmaceuticals, Inc butenafine hydrochloride cream 1% test product and Lotrimin Ultra cream (reference listed drug) in the treatment of interdigital tinea pedis, and to show the superiority of the active treatments over that of the placebo (vehicle).

NCT ID: NCT01110330 Terminated - Tinea Pedis Clinical Trials

An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot

Start date: July 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if a new formulation of ketoconazole 2% cream is as effective as a current formulation of ketoconazole 2% cream (Nizoral) compared with placebo in treating patients with Tinea pedis, a skin infection commonly known as "athlete's foot" that is caused by a kind of mold called a fungus.